# PerQseal®+ Early Feasibility Study

> **NCT05163548** · NA · COMPLETED · sponsor: **Vivasure Medical Limited** · enrollment: 15 (actual)

## Conditions studied

- Percutaneous Large Hole Vascular Closure

## Interventions

- **DEVICE:** PerQseal Plus Device

## Key facts

- **NCT ID:** NCT05163548
- **Lead sponsor:** Vivasure Medical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-08
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05163548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05163548, "PerQseal®+ Early Feasibility Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05163548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*